Strata Critical Medical, Inc. (SRTA) Stock Analysis — Probabli.AI
AI-powered analysis for SRTA (Strata Critical Medical, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $4.65 · Market cap: $393.2M · AI outlook: Bullish
Strata Critical Medical (SRTA) appears positioned for substantial medium to long-term growth driven by revolutionary medical devices and successful market expansion. Though short-term volatility and competition pose some risks, the strong revenue growth forecast and expert analyst sentiment underpin a generally bullish outlook. The company's ability to leverage innovative products and secure…
Probabilistic 1-Year Outlook
- Bull 55% · Neutral 30% · Bear 15%
- 1-year price estimates — P10: $3 / P50: $6 / P90: $8
- Strata Critical Medical, Inc. (SRTA) has demonstrated strong potential growth in revenue (1780% estimate) and analyst sentiment is very positive with a STRONG BUY consensus. Recent positive developments around FDA…
5-Year Outlook
- Bull 60% · Neutral 25% · Bear 15%
- 5-year price estimates — P10: $5 / P50: $16 / P90: $35
SWOT Highlights
- Strength: Innovative product pipeline including biodegradable stent technology.
- Strength: Robust analyst sentiment and STRONG BUY consensus.
- Risk: High volatility in earnings and share price.
- Risk: Negative avg EPS surprise indicates underperformance versus expectations.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
2 Wall Street analysts rate SRTA a STRONG BUY with a mean price target of $7.63.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
SRTA forecast details · SRTA sentiment details · SRTA insider activity
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.